Cannabidiol (CBD) clinical trials

Stratification and Treatment in Early Psychosis Study - PROMOTE

This study looks at whether a cannabis-based medicine (CBD) can help young people (aged 12-35) who are at high risk of developing psychosis. It also checks if CBD is safe and helps us understand how the brain works in these conditions.